Dermatologicals

2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…

Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations…

Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Retail sales of dermatologicals showed moderate growth in current value terms in 2023, with inflationary pressures less severe but still a factor. The dermatological category in Uzbekistan is an area lacking in development, largely due to the limited…

Hair weakens and becomes vulnerable to shedding due to reasons like seasonality (seasonal transitions), stress, hormonal changes and thermal applications. For this reason, hair loss treatments tends to see increases in demand in spring and autumn,…

Hair loss treatments is expected to continue to see strong retail volume and current value growth over 2023. Indeed, hair loss treatments is projected to record the fastest retail volume growth at the end of the review period. Mild-to-severe hair…

The dermatologicals landscape is experiencing a downward momentum in some categories, which have found themselves losing share and importance following the outbreak of COVID-19. Topical Germicidals/Antiseptics is one of the categories which is set to…

Top topical antifungals brands such as Canesten (Bayer), Lamisil (Haleon), and Unesia (Genomma) keep this segment competitive as each continues vying for more market share. Consumer demand for these products is expected to remain strong over the…

Despite another positive performance by dermatologicals in 2023, the category is recording significantly slower growth rates compared to 2022. The dynamic growth in 2022 was due to the fact that after the lifting of restrictions in Vietnam, local…

In general, dermatologicals was largely unaffected by the Coronavirus (COVID-19) pandemic. Most categories of dermatologicals continued to see retail volume growth in 2020, many of them at a similar rate to 2019. There are a number of underlying…

Dermatologicals has seen demand weaken in the post-pandemic period. While certain COVID-19 related habits, such as the use of hand sanitisers, remain relevant and people in Greece continue to use them much more than they did in the past, this is a…

Rising consumer demand for medicated skin care products continues to boost sales of dermatologicals in 2023. The desire for well-groomed and healthy skin is extending from beauty and personal care into dermatological products, although products in…

In the wake of the pandemic, marked by an increased emphasis on holistic health, skin health has experienced a robust resurgence in 2023. Forecasts indicate that dermatologicals is poised to achieve steady mid-single-digit current value growth in…

2023 saw rising demand for dermatologicals supported by the return to pre-pandemic daily routines and lifestyles as greater exposure to the causes of various mild skin conditions resulted in a higher incidence of skin infections and parasite-related…

Many consumers in South Africa rely on pharmacist recommendations when it comes to dermatological products. Most consumers within South Africa are highly unlikely to visit a doctor or even a dermatologist to treat some dermatological issues. As a…

Dermatologicals is expected to register moderate constant value and volume growth in 2023. Dermatologicals continues to recover from the removal of pandemic restrictions. With patients again visiting doctors for the last two years, this is a…

The sedentary lifestyles that are prevalent in Bulgaria significantly impact the market for dermatological products. A lack of physical activity often goes hand in hand with prolonged periods of sitting indoors, which can lead to reduced exposure to…

Dermatologicals in Tunisia is experiencing robust growth in current value terms in 2023 with this being driven by several factors that are contributing to the category’s success. One of the key drivers is the rising urbanisation of the population in…

Dermatologicals is set to register positive growth in current value and retail volume terms in 2023. With the WHO declaring the pandemic to be over in May 2023, there has been an increase in socialisation and physical contact between people which has…

Dermatologicals continued to record positive value growth in current price terms over the course of 2023 as the essential nature of many of these products for those experiencing moderate skin health issues ensured that demand remained relatively…

Dermatologicals is projected to continue to post strong retail current value growth in 2023. Increasing retail value sales have, on the one hand, been influenced by rising unit prices, amid a highly inflationary climate. In addition, hair loss…

Dermatologicals continues to achieve strong growth in 2023 driven by health and wellness trends and premiumisation in some product categories. Rising unit prices in response to inflation, which has impacted the entire consumer health category, has…

Demand for hair loss treatments is declining in 2023 following strong growth in recent years as COVID-19 and subsequent inflationary pressure boosted prevalence of hair loss due to stress and anxiety. Although the latter remains an overbearing issue…

Hair loss treatments in the United Arab Emirates has been experiencing increased fragmentation, due to the emergence of numerous new entrants, with the value share of the smallest players, included under “others” set to rise above 50% for the first…